« Back to Record
Citation APA

Coates, A., Keshaviah, A., Thürlimann, B., Mouridsen, H., Mauriac, L., Forbes, J. F., Paridaens, R., Castiglione-Gertsch, M., Gelber, R., Colleoni, M. A., Lang, I., Del Mastro, L., Smith, I., Chirgwin, J., Nogaret, J.-M., Pienkowski, T., Wardley, A., Jakobsen, E. H., Price, K., & Goldhirsch, A. (2007). Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. Journal of clinical oncology, 25(5), 486-492. doi:10.1200/JCO.2006.08.8617


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/120229

Coates, A., Keshaviah, A., Thürlimann, B., Mouridsen, H., Mauriac, L., Forbes, J. F., Paridaens, R., Castiglione-Gertsch, M., Gelber, R., Colleoni, M. A., Lang, I., Del Mastro, L., Smith, I., Chirgwin, J., Nogaret, J.-M., Pienkowski, T., Wardley, A., Jakobsen, E. H., Price, K., & Goldhirsch, A. (2007). Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. Journal of clinical oncology, 25(5), 486-492. doi:10.1200/JCO.2006.08.8617